OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CTNM

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Contineum Therapeutics (CTNM) Earnings Date & Reports

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CTNM is expected to report earnings to fall 3.23% to -60 cents per share on November 05

Contineum Therapeutics CTNM Stock Earnings Reports

Q3'25

Est.

$-0.60

Q2'25

Missed

by $0.34

Q1'25

Missed

by $0.20

Q4'24

Missed

by $0.11

Q3'24

Missed

by $0.04

The last earnings report on August 06 showed earnings per share of -62 cents, missing the estimate of -28 cents. With 183.76K shares outstanding, the current market capitalization sits at 167.39M.

View a ticker or compare two or three

Compare

CTNM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CTNM
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CTNM showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

10578 Science Center Drive

Phone

+1 858 333-5280

Employees

Web

https://www.contineum-tx.com